Cardax (CDXI) Stock Price, News & Analysis

Company Overview

Cardax, Inc. (OTCMKTS:CDXI) is a clinical-stage biotechnology company focused on the discovery and development of novel anti-inflammatory drug candidates. The company’s proprietary platform utilizes phospholipid-conjugated formulations of astaxanthin designed to enhance bioavailability and target chronic inflammatory and fibrotic conditions.

Cardax’s lead program, CARD-024, is advancing in preclinical development for the treatment of atherosclerosis and related cardiovascular diseases. In addition to its cardiovascular pipeline, the company is exploring immuno-oncology and gastrointestinal indications, leveraging its core technology to create differentiated therapeutic assets across multiple disease areas.

Headquartered in Honolulu, Hawaii, Cardax conducts its research and development activities primarily within the United States. The management team combines expertise in pharmaceutical sciences, clinical operations and regulatory affairs, positioning the company to progress its candidates through critical preclinical and early clinical milestones.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 15 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CDXI Stock Analysis - Frequently Asked Questions

How do I buy shares of Cardax?

Shares of CDXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardax own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardax investors own include Ashford Hospitality Trust (AHT), Peabody Energy (BTU), PlayAGS (AGS), Assertio (ASRT), Astronics (ATRO), CONSOL Coal Resources (CCR) and Alliance Resource Partners (ARLP).

Company Calendar

• Today: 10/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CDXI
• CIK: 1544238
• Web: www.cardaxpharma.com
• Phone: (808) 457-1400
• Fax: 808-237-5901
• Employees: 10
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 800,000
• Free Float: 566,000
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -0.30